Open access · OA
via OpenAlex
Heterogeneity in Cancer Metabolism: New Concepts in an Old Field
Géraldine Gentric, Virginie Mieulet, Fatima Mechta‐Grigoriou
Antioxidants and Redox Signaling · 2016 · ▲ 227 citations
Abstract
SIGNIFICANCE: In the last years, metabolic reprogramming, fluctuations in bioenergetic fuels, and modulation of oxidative stress became new key hallmarks of tumor development. In cancer, elevated glucose uptake and high glycolytic rate, as a source of adenosine triphosphate, constitute a growth advantage for tumors. This represents the universally known Warburg effect, which gave rise to one major clinical application for detecting cancer cells using glucose analogs: the positron emission tomography scan imaging. Recent Advances: Glucose utilization and carbon sources in tumors are much more heterogeneous than initially thought. Indeed, new studies emerged and revealed a dual capacity of tumor cells for glycolytic and oxidative phosphorylation (OXPHOS) metabolism. OXPHOS metabolism, which relies predominantly on mitochondrial respiration, exhibits fine-tuned regulation of respiratory chain complexes and enhanced antioxidant response or detoxification capacity. CRITICAL ISSUES: OXPHOS-dependent cancer cells use alternative oxidizable substrates, such as glutamine and fatty acids. The diversity of carbon substrates fueling neoplastic cells is indicative of metabolic heterogeneity, even within tumors sharing the same clinical diagnosis. Metabolic switch supports cancer cell stemness and their bioenergy-consuming functions, such as proliferation, survival, migration, and invasion. Moreover, reactive oxygen species-induced mitochondrial metabolism and nutrient availability are important for interaction with tumor microenvironment components. Carcinoma-associated fibroblasts and immune cells participate in the metabolic interplay with neoplastic cells. They collectively adapt in a dynamic manner to the metabolic needs of cancer cells, thus participating in tumorigenesis and resistance to treatments. FUTURE DIRECTIONS: Characterizing the reciprocal metabolic interplay between stromal, immune, and neoplastic cells will provide a better understanding of treatment resistance. Antioxid. Redox Signal. 26, 462-485.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1089/ars.2016.6750
- Canonical
- link ↗
- Fetched
- 2026-06-05 MST
Cite this
APA
Gentric, G., Mieulet, V., & Mechta‐Grigoriou, F. (2016). Heterogeneity in Cancer Metabolism: New Concepts in an Old Field. <em>Antioxidants and Redox Signaling</em>. https://doi.org/10.1089/ars.2016.6750
Vancouver
Gentric G, Mieulet V, Mechta‐Grigoriou F. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field. Antioxidants and Redox Signaling. 2016. doi:10.1089/ars.2016.6750.
BibTeX
@article{graldine2016Hetero,
title = {Heterogeneity in Cancer Metabolism: New Concepts in an Old Field},
author = {Géraldine Gentric and Virginie Mieulet and Fatima Mechta‐Grigoriou},
journal = {Antioxidants and Redox Signaling},
year = {2016},
doi = {10.1089/ars.2016.6750},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical and Translational Medicine 2016
Open access · CC-BY
Clinical significance of T cell metabolic reprogramming in cancer
Investigative Ophthalmology & Visual Science 2020
Open access · CC-BY
Reduced Oxidative Phosphorylation and Increased Glycolysis in Human Glaucoma Lamina Cribrosa Cells
Molecular Cancer Therapeutics 2011
Open access · OA
The Role of Autophagy in Cancer: Therapeutic Implications
Journal of Hematology & Oncology 2025
Open access · CC-BY
Target neutrophil heterogeneity and plasticity in cancer
Signal Transduction and Targeted Therapy 2023
Open access · CC-BY
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Cells 2019
Open access · CC-BY